Mundipharma launches Invokana and Vokanamet in Norway to treat type 2 diabetes
In line with the partnership with Janssen Pharmaceutica NV, Mundipharma now exclusively distributes and markets these treatments across 18 countries in the European Economic Area (EEA) and Switzerland.